Lv4
464 积分 2022-04-02 加入
A multicenter, randomized, double-blinded, placebo-controlled phase III trial to evaluate efficacy and safety of picankibart in moderate-to-severe plaque psoriasis
17小时前
已完结
B cell targeting in IgA nephropathy
1个月前
已完结
Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment
1个月前
已完结
Retrospective markers of paediatric atopic dermatitis persistence after hospital diagnosis: A nationwide cohort study
2个月前
已完结
Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Adults: A Six-Month Study
2个月前
已完结
Rapid and sustained response of stubborn guttate psoriasis to ustekinumab: a 52-week, two-centre, one-arm observational study
2个月前
已完结
Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial
2个月前
已完结
An overview of the efficacy and safety of systemic treatments for psoriasis in the elderly
2个月前
已完结
Studying the effect of systemic and biological drugs on intima‐media thickness in patients suffering from moderate and severe psoriasis
2个月前
已完结
Redefining the therapeutic objective in psoriatic patients candidates for biological therapy
2个月前
已完结
皖公网安备34019202002308
